Oncology Partner Content Ninth annual World Cancer Series: Europe will explore cancer... Conference to take place in Brussels from September 20-21
Oncology Partner Content 3rd Annual Tumor-Myeloid-Directed Therapies Summit Activating the myeloid compartment to tackle tumor suppression. Benchmark Novel Targets, Identify Appropriate Biomarkers & Unravel Myeloid Biology to Accelerate Clinical Translation of Myeloid-Targeted Combination Approaches.
Oncology Partner Content mRNA Cancer Vaccine Summit 2023 Bringing Novel & Effective mRNA Cancer Vaccines to Patients Faster
Oncology Partner Content Social Health and Cancer as a Chronic Condition The search for information, connection and validation for people living with a cancer diagnosis does not end when a person reaches no evidence of disease.
Oncology Partner Content CAR:T - Has biology outpaced the ability to deliver? CAR-T, the latest development in research is catapulting cell therapy to the headlines.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
